Lyfius Pharma Penicillin-G Plant Inaugurated by PM Modi
By Rediff Money Desk, New Delhi Oct 29, 2024 19:15
Lyfius Pharma, a unit of Aurobindo Pharma, inaugurated its Penicillin-G plant in Kakinada, Andhra Pradesh, by PM Modi. The facility, with a capacity of 15,000 MT, is a strategic investment under the PLI Scheme.
New Delhi, Oct 29 (PTI) Lyfius Pharma, a unit of Aurobindo Pharma, on Tuesday said Prime Minister Narendra Modi has inaugurated its Penicillin-G plant at Kakinada, Andhra Pradesh.
The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually inaugurated by Prime Minister Narendra Modi in the presence of Union Health Minister Jagat Prakash Nadda and other dignitaries.
The facility represents a strategic investment of Rs 2,500 crore under the government's PLI Scheme and exemplifies how private sector participation can significantly contribute to national growth, drive innovation, and enhance healthcare security, Lyfisu Pharma said in a regulatory filing.
The PLI scheme for the pharmaceutical sector aims to strengthen domestic manufacturing capabilities in critical KSMs, DIs, and APIs.
"The launch of our PenG facility is a significant milestone in our efforts to enhance local production and reduce import dependency for critical pharmaceutical ingredients," Lyfius Pharma Director MV Rama Krishna said.
The investment underscores the company's commitment to support the government's vision of 'Atmanirbhar Bharat', establishing India as a global pharmaceutical manufacturing hub, he added.
The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually inaugurated by Prime Minister Narendra Modi in the presence of Union Health Minister Jagat Prakash Nadda and other dignitaries.
The facility represents a strategic investment of Rs 2,500 crore under the government's PLI Scheme and exemplifies how private sector participation can significantly contribute to national growth, drive innovation, and enhance healthcare security, Lyfisu Pharma said in a regulatory filing.
The PLI scheme for the pharmaceutical sector aims to strengthen domestic manufacturing capabilities in critical KSMs, DIs, and APIs.
"The launch of our PenG facility is a significant milestone in our efforts to enhance local production and reduce import dependency for critical pharmaceutical ingredients," Lyfius Pharma Director MV Rama Krishna said.
The investment underscores the company's commitment to support the government's vision of 'Atmanirbhar Bharat', establishing India as a global pharmaceutical manufacturing hub, he added.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Thinkink Picturez
- 1.94 (+ 4.86)
- 69820171
- Rajnish Wellness
- 1.78 (+ 4.09)
- 54627483
- G G Engineering
- 1.80 (+ 1.12)
- 53423097
- GTL Infrastructure
- 2.32 ( 0.00)
- 34510899
- Vodafone Idea L
- 8.10 ( -0.25)
- 34418651
MORE NEWS
LIC Targets 1 Lakh Bima Sakhi for Women...
LIC aims to enroll 1 lakh Bima Sakhi in the next 12 months, spending Rs 840 crore on...
Pixxel Raises USD 24 Million for Satellite...
Google-backed space data firm Pixxel secures USD 24 million in Series B funding,...
Vodafone Idea Raises Rs 1,980 Cr Through...
Vodafone Idea's board has approved the issuance of up to 175.53 crore shares on a...